Revvity (RVTY) Current Deferred Revenue (2014 - 2016)
Revvity's (RVTY) quarterly Current Deferred Revenue came in at $163.2 million in Q1 2016, down 3.41% YoY from $168.9 million in Q1 2015, and down 3.41% on a QoQ basis from $168.9 million in Q4 2014.
Revvity (RVTY) Current Deferred Revenue (2014 - 2016) Analysis & Trends
Revvity (RVTY) has 2 years of Current Deferred Revenue data on file, last reported at $163.2 million in Q1 2016.
- Quarterly Current Deferred Revenue fell 3.41% year-over-year to $163.2 million in Q1 2016, while the trailing twelve-month figure through Jan 2016 was $163.2 million (down 3.41% YoY) and the FY2016 annual result came in at $163.2 million, down 3.41% from the prior year.
- Current Deferred Revenue slipped to $163.2 million in Q1 2016, from $168.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $168.9 million in Q4 2014 to a low of $163.2 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2016 | 163.17 Mn |
| Dec 28, 2014 | 168.93 Mn |